Mood changes correlate to changes in brain serotonin precursor trapping in women with premenstrual dysphoria

Psychiatry Research - Neuroimaging

Volumn 146, Issue 2, 2006, Pages 107-116

  Eriksson, Olle ^a   Wall, Anders ^a   Marteinsdottir, Ina ^a   Ågren, Hans ^b   Hartvig, Per ^a   Blomqvist, Gunnar ^a   Långström, Bengt ^a   Naessén, Tord ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

5 Hydroxytryptophan; Affective symptoms; Positron emission tomography; Premenstrual dysphoric disorder; Premenstrual syndrome; Right caudate nucleus

Indexed keywords

5 HYDROXYTRYPTOPHAN; BRAIN PROTEIN; CARBON 11; SEROTONIN;

ADULT; ARTICLE; CAUDATE NUCLEUS; CLINICAL ARTICLE; CORRELATION ANALYSIS; DEPRESSION; DIAGNOSTIC IMAGING; DISEASE EXACERBATION; EMOTIONAL DISORDER; FEMALE; HUMAN; HYPOTHESIS; IRRITABILITY; MENSTRUAL CYCLE; MOOD CHANGE; MOOD DISORDER; NEUROIMAGING; OVARY FOLLICLE; POSITRON EMISSION TOMOGRAPHY; PREMENSTRUAL DYSPHORIC DISORDER; PREMENSTRUAL SYNDROME; PRIORITY JOURNAL; RATING SCALE; VISUAL ANALOG SCALE;

5-HYDROXYTRYPTOPHAN; BRAIN; CAUDATE NUCLEUS; FEMALE; FUNCTIONAL LATERALITY; HUMANS; MOOD DISORDERS; POSITRON-EMISSION TOMOGRAPHY; PREMENSTRUAL SYNDROME; SEROTONIN; VISUAL PERCEPTION;

EID: 33645885004     PISSN: 09254927     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pscychresns.2005.02.012     Document Type: Article

References (64)

1. Ågren H., and Reibring L. PET studies of presynaptic monoamine metabolism in depressed patients and healthy volunteers. Pharmacopsychiatry 27 1 (1994) 2-6
2. 11C-5-hydroxytryptophan in major depression: a positron emission tomography study on patients and healthy volunteers. Acta Psychiatrica Scandinavica 83 (1991) 449-455
3. American Psychiatric Association. DSM-IV: Diagnostic and Statistical Manual of Mental Disorders (1994), APA, Washington, DC
4. Andersson J.L.R. A rapid and accurate method to realign PET scans utilizing image edge transformation. Journal of Nuclear Medicine 36 (1995) 657-669
5. Arancibia S., Rage F., Astier H., and Tapia-Arancibia L. Neuroendocrine and autonomous mechanisms underlying thermoregulation in cold environment. Neuroendocrinology 64 4 (1996) 257-267
6. Bjurling P., Watanabe Y., Tokushige M., Oda T., and Långström B. Synthesis of beta-II-l-tryptophan and 5-hydroxy-l-tryptophan using a multi-enzymatic reaction route. Journal of the Chemical Society. Perkin Transactions 1 1 (1989) 1331-1334
7. Bjurling P., Antoni G., Watanabe Y., and Långström B. Enzymatic synthesis of carboxy-carbon-11-labelled l-tyrosine, l-DOPA, l-tryptophan and 5-hydroxy-l-tryptophan. Acta Chemica Scandinavica 44 2 (1990) 178-182
8. Brody A.L., Barsom M.W., Bota R.G., and Saxena S. Prefrontal-subcortical and limbic circuit mediation of major depressive disorder. Seminars in Clinical Neuropsychiatry 6 2 (2001) 102-112
9. Bruck A., Portin R., Lindell A., Laihinen A., Bergman J., Haaparanta M., Solin O., and Rinne J.O. Positron emission tomography shows that impaired frontal lobe functioning in Parkinson's disease is related to dopaminergic hypofunction in the caudate nucleus. Neuroscience Letters 311 2 (2001) 81-84
10. Brzezinski A.A., Wurtman J.J., Wurtman R.J., Gleason R., Greenfield J., and Nader T. d-Fenfluramine suppresses the increased calorie and carbohydrate intakes and improves the mood of women with premenstrual depression. Obstetrics and Gynecology 76 2 (1990) 296-301
11. Bucht G., Adolfsson R., Gottfries C.G., Roos B.E., and Winblad B. Distribution of 5-hydroxytryptamine and 5-hydroxyindoleacetic acid in human brain in relation to age, drug influence, agonal status and circadian variation. Journal of Neural Transmission. General Section 51 3-4 (1981) 185-203
12. Castellanos F.X., Giedd J.N., Eckburg P., Marsh W.L., Vaituzis A.C., Kaysen D., Hamburger S.D., and Rapoport J.L. Quantitative morphology of the caudate nucleus in attention deficit hyperactivity disorder. American Journal of Psychiatry 151 12 (1994) 1791-1796
13. Churchill G.A., and Doerge R.W. Empirical threshold values for quantitative trait mapping. Genetics 138 (1994) 963-971
14. Cohen L.S., Miner C., Brown E.W., Freeman E., Halbreich U., Sundell K., and McCray S. Premenstrual daily fluoxetine for premenstrual dysphoric disorder: a placebo-controlled, clinical trial using computerized diaries. Obstetrics and Gynecology 100 3 (2002) 435-444
15. Davidson R.J. Anxiety and affective style: role of prefrontal cortex and amygdala. Biological Psychiatry 51 1 (2002) 68-80
16. Dimmock P.W., Wyatt K.M., Jones P.W., and O'Brien P.M. Efficacy of selective serotonin-reuptake inhibitors in premenstrual syndrome: a systematic review. Lancet 356 9236 (2000) 1131-1136
17. Dye L., and Blundell J.E. Menstrual cycle and appetite control: implications for weight regulation. Human Reproduction 12 6 (1997) 1142-1151
18. Eaton M.J., Gudehithlu K.P., Quach T., Silvia C.P., Hadjiconstantinou M., and Neff N.H. Distribution of aromatic l-amino acid decarboxylase mRNA in mouse brain by in situ hybridization histology. Journal of Comparative Neurology 337 4 (1993) 640-654
19. Eriksson E. Serotonin reuptake inhibitors for the treatment of premenstrual dysphoria. International Clinical Psychopharmacology 14 Suppl 2 (1999) S27-S33
20. Eriksson E., Hedberg M.A., Andersch B., and Sundblad C. The serotonin reuptake inhibitor paroxetine is superior to the noradrenaline reuptake inhibitor maprotiline in the treatment of premenstrual syndrome. Neuropsychopharmacology 12 2 (1995) 167-176
21. Eriksson E., Andersch B., Ho H.P., Landen M., and Sundblad C. Diagnosis and treatment of premenstrual dysphoria. Journal of Clinical Psychiatry 63 Suppl. 7 (2002) 16-23
22. Fernstrom J.D. Tryptophan, serotonin and carbohydrate appetite: will the real carbohydrate craver please stand up!. Journal of Nutrition 118 11 (1988) 1417-1419
23. Fernstrom J.D., and Wurtman R.J. Brain serotonin content: physiological regulation by plasma neutral amino acids. Science 178 59 (1972) 414-416
24. In: First M.B., Spitzer R.L., Gibbon M., Williams J.B., and Benjamin L. (Eds). Structured Clinical Interview for DSM-IV (1995), New York State Psychiatric Institute, New York
25. Greitz T., Bohm C., Holte S., and Eriksson L. A computerized brain atlas: construction, anatomical content, and some applications. Journal of Computer Assisted Tomography 15 (1991) 26-38
26. 11C]-5-hydroxy-l-tryptophan for PET assessment of serotonin synthesis in human brain. Journal of Cerebral Blood Flow and Metabolism 22 11 (2002) 1352-1366
27. Hammarbäck S., Bäckström T., and MacGibbon-Taylor B. Diagnosis of premenstrual tension syndrome: description and evaluation of a procedure for diagnosis and differential diagnosis. Journal of Psychosomatic Obstetrics and Gynaecology 10 (1989) 25-42
28. 11C-labelled l-tryptophan and 5-hydroxy-l-tryptophan in the rhesus monkey. A study using positron emission tomography. Journal of Neural Transmission. General Section 88 1 (1992) 1-10
29. Hartvig P., Tedroff J., Lindner K.J., Bjurling P., Chang C.W., Tsukada H., Watanabe Y., and Långström B. Positron emission tomographic studies on aromatic l-amino acid decarboxylase activity in vivo for l-DOPA and 5-hydroxy-l-tryptophan in the monkey brain. Journal of Neural Transmission. General Section 94 2 (1993) 127-135
30. Hokfelt T., Fuxe K., and Goldstein M. Immunohistochemical localization of aromatic l-amino acid decarboxylase (DOPA decarboxylase) in central dopamine and 5-hydroxytryptamine nerve cell bodies of the rat. Brain Research 53 1 (1973) 175-180
31. Holte S., Eriksson L., and Dahlbom M. A preliminary evaluation of the Scanditronix PC2048-15B brain scanner. European Journal of Nuclear Medicine 15 11 (1989) 719-721
32. Ifthikharuddin S.F., Shrier D.A., Numaguchi Y., Tang X., Ning R., Shibata D.K., and Kurlan R. MR volumetric analysis of the human basal ganglia: normative data. Academic Radiology 7 8 (2000) 627-634
33. Jacobs B.L., and Fornal C.A. Serotonin and motor activity. Current Opinion in Neurobiology 7 6 (1997) 820-825
34. Jaeger C., Teitelman G., Joh T., Albert V., Park D., and Reis D. Some neurones of the rat central nervous system contain aromatic-l-amino-acid decarboxylase but not monoamines. Science 219 4589 (1983) 1233-1235
35. Kaya G.C., Pekcanlar A., Bekis R., Ada E., Miral S., Emiroglu N., and Durak H. Technetium-99m HMPAO brain SPECT in children with attention deficit hyperactivity disorder. Annals of Nuclear Medicine 16 8 (2002) 527-531
36. Landen M., Eriksson O., Sundblad C., Andersch B., Naessen T., and Eriksson E. Compounds with affinity for serotonergic receptors in the treatment of premenstrual dysphoria: a comparison of buspirone, nefazodone and placebo. Psychopharmacology 155 3 (2001) 292-298
37. 11C]tryptophan and its in vivo-formed radiolabeled metabolites in brain tissue using high performance liquid chromatography: a study supporting radiotracer kinetics obtained with positron emission tomography. Nuclear Medicine and Biology 24 8 (1997) 733-738
38. Lloyd K.G., and Hornykiewicz O. Occurrence and distribution of aromatic l-amino acid (l-DOPA) decarboxylase in the human brain. Journal of Neurochemistry 19 6 (1972) 1549-1559
39. Mackay A.V., Davies P., Dewar A.J., and Yates C.M. Regional distribution of enzymes associated with neurotransmission by monoamines, acetylcholine and GABA in the human brain. Journal of Neurochemistry 30 4 (1978) 827-839
40. Menkes D.B., Coates D.C., and Fawcett J.P. Acute tryptophan depletion aggravates premenstrual syndrome. Journal of Affective Disorders 32 1 (1994) 37-44
41. Mountz J.M., Bradley L.A., Modell J.G., Alexander R.W., Triana-Alexander M., Aaron L.A., Stewart K.E., Alarcon G.S., and Mountz J.D. Fibromyalgia in women. Abnormalities of regional cerebral blood flow in the thalamus and the caudate nucleus are associated with low pain threshold levels. Arthritis and Rheumatism 38 7 (1995) 926-938
42. Nagatsu T., Yamamoto T., and Kato T. A new and highly sensitive voltammetric assay for aromatic l-amino acid decarboxylase activity by high-performance liquid chromatography. Analytical Biochemistry 100 1 (1979) 160-165
43. Nishizawa S., Benkelfat C., Young S.N., Leyton M., Mzengeza S., de Montigny C., Blier P., and Diksic M. Differences between males and females in rates of serotonin synthesis in human brain. Proceedings of the National Academy of Sciences of the United States of America 94 10 (1997) 5308-5313
44. Parry B.L. The role of central serotonergic dysfunction in the aetiology of premenstrual dysphoric disorder: therapeutic implications. CNS Drugs 15 4 (2001) 277-285
45. Partonen T., and Lonnqvist J. Seasonal affective disorder. Lancet 352 9137 (1998) 1369-1374
46. Rapkin A. A review of treatment of premenstrual syndrome and premenstrual dysphoric disorder. Psychoneuroendocrinology 28 Suppl. 3 (2003) 39-53
47. Rehman H.U., and Masson E.A. Neuroendocrinology of ageing. Age and Ageing 30 4 (2001) 279-287
48. Robbins T.W. From arousal to cognition: the integrative position of the prefrontal cortex. Progress in Brain Research 126 (2000) 469-483
49. 18F]fluoro-l-DOPA studied with PET in normal control and Parkinson's disease subjects. Synapse 37 2 (2000) 81-89
50. Stefanatos G.A., and Wasserstein J. Attention deficit/hyperactivity disorder as a right hemisphere syndrome. Selective literature review and detailed neuropsychological case studies. Annals of the New York Academy of Sciences 931 (2001) 172-195
51. Steinberg S., Annable L., Young S.N., and Belanger M.C. Tryptophan in the treatment of late luteal phase dysphoric disorder: a pilot study. Journal of Psychiatry & Neuroscience 19 2 (1994) 114-119
52. Steiner M., and Pearlstein T. Premenstrual dysphoria and the serotonin system: pathophysiology and treatment. Journal of Clinical Psychiatry 61 Suppl. 12 (2000) 17-21
53. Steiner M., Steinberg S., Stewart D., Carter D., Berger C., Reid R., Grover D., and Streiner D. Fluoxetine in the treatment of premenstrual dysphoria. Canadian Fluoxetine/Premenstrual Dysphoria Collaborative Study Group. New England Journal of Medicine 332 23 (1995) 1529-1534
54. Steiner M., Romano S.J., Babcock S., Dillon J., Shuler C., Berger C., Carter D., Reid R., Stewart D., Steinberg S., and Judge R. The efficacy of fluoxetine in improving physical symptoms associated with premenstrual dysphoric disorder. British Journal of Obstetrics and Gynaecology 108 5 (2001) 462-468
55. Su T.P., Schmidt P.J., Danaceau M., Murphy D.L., and Rubinow D.R. Effect of menstrual cycle phase on neuroendocrine and behavioral responses to the serotonin agonist m-chlorophenylpiperazine in women with premenstrual syndrome and controls. Journal of Clinical Endocrinology and Metabolism 82 4 (1997) 1220-1228
56. Tiihonen J., Vilkman H., Rasanen P., Ryynanen O.P., Hakko H., Bergman J., Hamalainen T., Laakso A., Haaparanta-Solin M., Solin O., Kuoppamaki M., Syvalahti E., and Hietala J. Striatal presynaptic dopamine function in type 1 alcoholics measured with positron emission tomography. Molecular Psychiatry 3 2 (1998) 156-161
57. Trulson M.E., and Jacobs B.L. Raphe unit activity in freely moving cats: correlation with level of behavioral arousal. Brain Research 163 1 (1979) 135-150
58. Ursin R. Serotonin and sleep. Sleep Medicine Reviews 6 1 (2002) 55-69
59. Watkins K.E., Paus T., Lerch J.P., Zijdenbos A., Collins D.L., Neelin P., Taylor J., Worsley K.J., and Evans A.C. Structural asymmetries in the human brain: a voxel-based statistical analysis of 142 MRI scans. Cerebral Cortex 11 9 (2001) 868-877
60. Wichers M., and Maes M. The psychoneuroimmuno-pathophysiology of cytokine-induced depression in humans. International Journal of Neuropsychopharmacology 5 4 (2002) 375-388
61. Wurtman J.J. Carbohydrate craving. Relationship between carbohydrate intake and disorders of mood. Drugs 39 Suppl. 3 (1990) 49-52
62. Wurtman J.J., Brzezinski A., Wurtman R.J., and Laferrere B. Effect of nutrient intake on premenstrual depression. American Journal of Obstetrics and Gynecology 161 5 (1989) 1228-1234
63. Yamato T., Yamasaki S., Misumi Y., Kino M., Obata T., and Aomine M. Modulation of the stress response by coffee: an in vivo microdialysis study of hippocampal serotonin and dopamine levels in rat. Neuroscience Letters 332 2 (2002) 87-90
64. Yonkers K.A., Halbreich U., Freeman E., Brown C., Endicott J., Frank E., Parry B., Pearlstein T., Severino S., Stout A., Stone A., and Harrison W. Symptomatic improvement of premenstrual dysphoric disorder with sertraline treatment. A randomized controlled trial. Sertraline Premenstrual Dysphoric Collaborative Study Group. JAMA: The Journal of the American Medical Association 278 12 (1997) 983-988